132 related articles for article (PubMed ID: 12648052)
1. Fungal granuloma following ruthenium plaque radiotherapy of a choroidal melanoma.
Okera S; Dodd T; Selva D; Muecke J
Clin Exp Ophthalmol; 2003 Apr; 31(2):159-61. PubMed ID: 12648052
[No Abstract] [Full Text] [Related]
2. Multilobular choroidal melanoma following ruthenium 106 brachytherapy.
Pe'er J; Barzel I
Arch Ophthalmol; 2005 Jun; 123(6):868-9. PubMed ID: 15955993
[No Abstract] [Full Text] [Related]
3. Recurrent choroidal melanoma after brachytherapy in an eye with scleral calcification.
Russo A; Coupland SE; Raja V; Damato BE
Acta Ophthalmol; 2011 Dec; 89(8):e657-8. PubMed ID: 20946331
[No Abstract] [Full Text] [Related]
4. Ruthenium applicators in the treatment of choroidal melanomas.
Van Hijfte R; Verbraeken H; De Laey JJ
Bull Soc Belge Ophtalmol; 1987; 224():51-8. PubMed ID: 3509023
[No Abstract] [Full Text] [Related]
5. Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy.
Papageorgiou KI; Cohen VM; Bunce C; Kinsella M; Hungerford JL
Br J Ophthalmol; 2011 Feb; 95(2):166-70. PubMed ID: 20889528
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
[TBL] [Abstract][Full Text] [Related]
7. Anterior Segment OCT of Scleral Necrosis after Plaque Radiotherapy for Choroidal Melanoma.
Pontarelli MK; Sajjadi Z; Shields CL
Ophthalmol Retina; 2021 Nov; 5(11):1084. PubMed ID: 34752302
[No Abstract] [Full Text] [Related]
8. Plaque radiotherapy for management of ciliary body and choroidal melanoma with extraocular extension.
Gündüz K; Shields CL; Shields JA; Cater J; Brady L
Am J Ophthalmol; 2000 Jul; 130(1):97-102. PubMed ID: 11004266
[TBL] [Abstract][Full Text] [Related]
9. Choroidal melanoma metastatic to the contralateral choroid.
Singh AD; Shields JA; Shields CL; Sato T
Am J Ophthalmol; 2001 Dec; 132(6):941-3. PubMed ID: 11730671
[TBL] [Abstract][Full Text] [Related]
10. A case of quiescent choroidal melanoma: early echographic signs of reactivation.
Mancini A; Colangelo L; Lapi G; Lobefalo L; Ciancaglini M; Mastropasqua L; Gallenga PE
Ophthalmologica; 1998; 212 Suppl 1():57-60. PubMed ID: 9730753
[TBL] [Abstract][Full Text] [Related]
11. [High-dose 106Ruthenium plaque brachytherapy for posterior uveal melanoma. A clinico-pathologic study].
Heindl LM; Lotter M; Strnad V; Sauer R; Naumann GO; Knorr HL
Ophthalmologe; 2007 Feb; 104(2):149-57. PubMed ID: 17123048
[TBL] [Abstract][Full Text] [Related]
12. Comparative outcomes and toxicities for ruthenium-106 versus palladium-103 in the treatment of choroidal melanoma.
Danish H; Ferris MJ; Balagamwala E; Switchenko JM; Patel KR; Choudhary M; Craven C; Mendoza P; Suh J; Bergstrom C; Grossniklaus HE; M Aaberg T; Singh A; Crocker IR; Khan MK
Melanoma Res; 2018 Apr; 28(2):120-125. PubMed ID: 29303890
[TBL] [Abstract][Full Text] [Related]
13. Scleral Necrosis Simulating Recurrent Uveal Melanoma after Plaque Brachytherapy.
Burris CKH; Rodriguez ME; Potter HD
Ophthalmology; 2016 Aug; 123(8):1761. PubMed ID: 27450820
[No Abstract] [Full Text] [Related]
14. Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma.
Verschueren KM; Creutzberg CL; Schalij-Delfos NE; Ketelaars M; Klijsen FL; Haeseker BI; Ligtenberg SM; Keunen JE; Marijnen CA
Radiother Oncol; 2010 Jun; 95(3):332-8. PubMed ID: 20416963
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal bevacizumab treatment of radiation maculopathy due to brachytherapy in choroidal melanoma.
Ziemssen F; Voelker M; Altpeter E; Bartz-Schmidt KU; Gelisken F
Acta Ophthalmol Scand; 2007 Aug; 85(5):579-80. PubMed ID: 17324216
[No Abstract] [Full Text] [Related]
16. Outcome Analysis of Visual Acuity and Side Effect after Ruthenium-106 Plaque Brachytherapy for Medium-sized Choroidal Melanoma.
AlMahmoud T; Quinlan-Davidson S; Pond GR; Deschênes J
Middle East Afr J Ophthalmol; 2018; 25(2):103-107. PubMed ID: 30122856
[TBL] [Abstract][Full Text] [Related]
17. Does choroidal melanoma regression correlate with chromosome 3 loss after ruthenium brachytherapy?
Chiam PJ; Coupland SE; Kalirai H; Groenewald C; Heimann H; Damato BE
Br J Ophthalmol; 2014 Jul; 98(7):967-71. PubMed ID: 24518077
[TBL] [Abstract][Full Text] [Related]
18. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
19. [Risk factors for the recurrence of choroidal melanoma after the Ru-106 brachytherapy].
Bogdali A; Romanowska-Dixon B
Klin Oczna; 2015; 117(3):169-72. PubMed ID: 26999940
[TBL] [Abstract][Full Text] [Related]
20. Choroidal melanoma suspect. Conservative treatment and evolution. Case report.
Zemba M; Malciolu RA
Rom J Ophthalmol; 2016; 60(4):264-269. PubMed ID: 29450360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
